{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T10:38:23Z","timestamp":1791974303455,"version":"4.4.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatol Commun"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:p>The impact of circulating microRNA\u2010122 (miR\u2010122) on mortality in patients with histopathologically confirmed nonalcoholic fatty liver disease (NAFLD) remains unclear. We analyzed the overall survival rates in 441 Japanese patients with histopathologically confirmed NAFLD after a median follow\u2010up period of 4.7 years. We also determined the clinicopathologic, genetic, and epigenetic parameters, including serum miR\u2010122 levels, for prediction of mortality. Of the 441 study patients, 21 (4.8%) died during the follow\u2010up period. The cumulative survival rates were 95.4% and 90.6% at the end of 5 and 10 years, respectively. Multivariate analysis identified history of liver cancer (presence; hazard ratio [HR], 4.94; 95% confidence interval [CI], 1.84\u201013.3), serum miR\u2010122 (&lt;1.00 fold change; HR, 4.35; 95% CI, 0.06\u20100.83), and fibrosis\u20104 index (FIB\u20104 index) (\u22651.30; HR, 15.7; 95% CI, 2.01\u2010122) as significant risk factors of mortality. Cumulative survival rates varied significantly among patients with none\/one risk factor, two risk factors, and three risk factors; particularly, the survival rate of patients with three risk factors was significantly lower than those with two risk factors and none\/one risk factor. Two or more risk factors were identified in 17 of 21 (81.0%) death cases. <jats:italic toggle=\"yes\">Conclusion:<\/jats:italic> The importance of serum miR\u2010122 and FIB\u20104 index as risk factors for mortality in Japanese patients with histopathologically confirmed NAFLD is shown. Early diagnosis based on the presence of more than one risk factor and early treatment might improve the prognosis.<\/jats:p>","DOI":"10.1002\/hep4.1445","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T15:53:40Z","timestamp":1572969220000},"page":"66-76","source":"Crossref","is-referenced-by-count":19,"title":["Circulating MicroRNA\u2010122 and Fibrosis Stage Predict Mortality of Japanese Patients With Histopathologically Confirmed NAFLD"],"prefix":"10.1097","volume":"4","author":[{"given":"Norio","family":"Akuta","sequence":"first","affiliation":[{"name":"Department of Hepatology,Toranomon Hospital and Okinaka Memorial Institute for Medical Research,Tokyo,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kawamura","sequence":"additional","affiliation":[{"name":"Department of Hepatology,Toranomon Hospital and Okinaka Memorial Institute for Medical Research,Tokyo,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuji","family":"Arase","sequence":"additional","affiliation":[{"name":"Department of Hepatology,Toranomon Hospital and Okinaka Memorial Institute for Medical Research,Tokyo,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Saitoh","sequence":"additional","affiliation":[{"name":"Department of Hepatology,Toranomon Hospital and Okinaka Memorial Institute for Medical Research,Tokyo,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichiro","family":"Fujiyama","sequence":"additional","affiliation":[{"name":"Department of Hepatology,Toranomon Hospital and Okinaka Memorial Institute for Medical Research,Tokyo,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4282-0934","authenticated-orcid":false,"given":"Hitomi","family":"Sezaki","sequence":"additional","affiliation":[{"name":"Department of Hepatology,Toranomon Hospital and Okinaka Memorial Institute for Medical Research,Tokyo,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Hosaka","sequence":"additional","affiliation":[{"name":"Department of Hepatology,Toranomon Hospital and Okinaka Memorial Institute for Medical Research,Tokyo,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Hepatology,Toranomon Hospital and Okinaka Memorial Institute for Medical Research,Tokyo,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Liver Research Laboratory,Toranomon Hospital,Tokyo,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Hepatology,Toranomon Hospital and Okinaka Memorial Institute for Medical Research,Tokyo,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitaka","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Hepatology,Toranomon Hospital and Okinaka Memorial Institute for Medical Research,Tokyo,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Hepatology,Toranomon Hospital and Okinaka Memorial Institute for Medical Research,Tokyo,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Kumada","sequence":"additional","affiliation":[{"name":"Department of Hepatology,Toranomon Hospital and Okinaka Memorial Institute for Medical Research,Tokyo,Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,11,5]]},"reference":[{"key":"hep41445-bib-0001-20240114","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","article-title":"Nonalcoholic fatty liver disease","volume":"346","year":"2002","journal-title":"N Engl J Med"},{"key":"hep41445-bib-0002-20240114","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/hep.21347","article-title":"Global challenges in liver disease","volume":"44","year":"2006","journal-title":"Hepatology"},{"key":"hep41445-bib-0003-20240114","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1053\/j.gastro.2008.02.077","article-title":"Diagnosis and therapy of nonalcoholic steatohepatitis","volume":"134","year":"2008","journal-title":"Gastroenterology"},{"key":"hep41445-bib-0004-20240114","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.22603","article-title":"Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management","volume":"49","year":"2009","journal-title":"Hepatology"},{"key":"hep41445-bib-0005-20240114","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3748\/wjg.v20.i2.475","article-title":"Limitations of liver biopsy and non\u2010invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"20","year":"2014","journal-title":"World J Gastroenterol"},{"key":"hep41445-bib-0006-20240114","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12876-018-0900-1","article-title":"Hepatocellular carcinoma is the most common liver\u2010related complication in patients with histopathologically\u2010confirmed NAFLD in Japan","volume":"18","year":"2018","journal-title":"BMC Gastroenterol"},{"key":"hep41445-bib-0007-20240114","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0032-1306421","article-title":"Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research","volume":"32","year":"2012","journal-title":"Semin Liver Dis"},{"key":"hep41445-bib-0008-20240114","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/hep.24268","article-title":"Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver\u2010related mortality","volume":"53","year":"2011","journal-title":"Hepatology"},{"key":"hep41445-bib-0009-20240114","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long\u2010term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","year":"2015","journal-title":"Gastroenterology"},{"key":"hep41445-bib-0010-20240114","article-title":"Circulating microRNAs in patients with chronic hepatitis C and non\u2010alcoholic fatty liver disease","volume":"6","year":"2011","journal-title":"PLoS One"},{"key":"hep41445-bib-0011-20240114","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/gutjnl-2014-306996","article-title":"Circulating microRNA signature in non\u2010alcoholic fatty liver disease: from serum non\u2010coding RNAs to liver histology and disease pathogenesis","volume":"64","year":"2015","journal-title":"Gut"},{"key":"hep41445-bib-0012-20240114","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s12072-016-9729-2","article-title":"Impact of circulating miR\u2010122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan","volume":"10","year":"2016","journal-title":"Hepatol Int"},{"key":"hep41445-bib-0013-20240114","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep4.1019","article-title":"Effects of a sodium\u2010glucose cotransporter 2 inhibitor in nonalcoholic fatty liver disease complicated by diabetes mellitus: preliminary prospective study based on serial liver biopsies","volume":"1","year":"2017","journal-title":"Hepatol Commun"},{"key":"hep41445-bib-0014-20240114","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","year":"2005","journal-title":"Hepatology"},{"key":"hep41445-bib-0015-20240114","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"hep41445-bib-0016-20240114","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/hep.27173","article-title":"Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease","volume":"60","year":"2014","journal-title":"Hepatology"},{"key":"hep41445-bib-0017-20240114","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","year":"2006","journal-title":"Hepatology"},{"key":"hep41445-bib-0018-20240114","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ymeth.2010.01.032","article-title":"Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription\u2010PCR (qRT\u2010PCR)","volume":"50","year":"2010","journal-title":"Methods"},{"key":"hep41445-bib-0019-20240114","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1210\/jc.2011-3059","article-title":"Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma","volume":"97","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"hep41445-bib-0020-20240114","article-title":"miR\u201020a\u20105p regulates pulmonary surfactant gene expression in alveolar type II cells","year":"2019","journal-title":"J Cell Mol Med"},{"key":"hep41445-bib-0021-20240114","article-title":"Serum microRNA\u2010122 predicts survival in patients with liver cirrhosis","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"hep41445-bib-0022-20240114","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.1016\/j.ejca.2013.06.002","article-title":"Serum microRNA\u20101 and microRNA\u2010122 are prognostic markers in patients with hepatocellular carcinoma","volume":"49","year":"2013","journal-title":"Eur J Cancer"},{"key":"hep41445-bib-0023-20240114","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1007\/s13277-015-3128-5","article-title":"High serum microRNA\u2010122 level is independently associated with higher overall survival rate in hepatocellular carcinoma patients","volume":"36","year":"2015","journal-title":"Tumour Biol"},{"key":"hep41445-bib-0024-20240114","article-title":"The clinical significance of microRNA\u2010122 in predicting the prognosis of patients with hepatocellular carcinoma: a meta\u2010analysis validated by the Cancer Genome Atlas dataset","volume":"98","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"hep41445-bib-0025-20240114","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/hepr.13078","article-title":"microRNAs as possible biomarkers for hepatocellular carcinoma","volume":"48","year":"2018","journal-title":"Hepatol Res"},{"key":"hep41445-bib-0026-20240114","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","year":"2008","journal-title":"Nat Genet"},{"key":"hep41445-bib-0027-20240114","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s12328-018-0841-9","article-title":"The genetic backgrounds in nonalcoholic fatty liver disease","volume":"11","year":"2018","journal-title":"Clin J Gastroenterol"},{"key":"hep41445-bib-0028-20240114","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome\u2010wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","year":"2014","journal-title":"Nat Genet"}],"container-title":["Hepatology Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep4.1445","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/hep4.1445","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/10.1002\/hep4.1445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T17:01:51Z","timestamp":1705251711000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1002\/hep4.1445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,5]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1002\/hep4.1445","relation":{},"ISSN":["2471-254X","2471-254X"],"issn-type":[{"value":"2471-254X","type":"print"},{"value":"2471-254X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,5]]}}}